BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7078819)

  • 1. [Value of the radioimmunologic measurement of serum trypsin in the study of pancreatic diseases. Preliminary studies].
    Cipollini F; Anichini M; Altilia F
    Minerva Med; 1982 May; 73(20):1425-8. PubMed ID: 7078819
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of trypsin radioimmunoassay in pancreas diagnosis].
    Koop H; Lankisch PG; Arnold R
    Dtsch Med Wochenschr; 1980 Jun; 105(24):846-7. PubMed ID: 7418614
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma trypsin-like immunoreactivity in normal subjects and in patients with pancreatic diseases.
    Adrian TE
    Scand J Gastroenterol Suppl; 1980; 62():15-20. PubMed ID: 6935750
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma alpha 2-macroglobulin-trypsin complexlike substance (MTLS) in pancreatic disease.
    Kato M; Hayakawa S; Naruse S; Kitagawa M; Nakae Y; Hayakawa T
    J Clin Lab Anal; 1996; 10(6):399-402. PubMed ID: 8951609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of serum levels of trypsin in the diagnosis of pancreatic diseases].
    Wacheck W
    Ric Clin Lab; 1983; 13 Suppl 2():119-24. PubMed ID: 6199827
    [No Abstract]   [Full Text] [Related]  

  • 6. [Importance of the trypsin radioimmunoassay in pancreatic diagnosis].
    Koop H; Langkisch PG; Arnold R
    Minerva Dietol Gastroenterol; 1983; 29(3):251-3. PubMed ID: 6633919
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis.
    Appelros S; Petersson U; Toh S; Johnson C; Borgström A
    Br J Surg; 2001 Feb; 88(2):216-21. PubMed ID: 11167870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum antibodies in human pancreatic disease.
    Lendrum R; Walker G
    Gut; 1975 May; 16(5):365-71. PubMed ID: 1095452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of pancreatic disease (radioimmunological method for trypsin levels in blood].
    Felber JP
    Ric Clin Lab; 1980; 10 Suppl 2():55-8. PubMed ID: 7232993
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic importance of changes in circulating concentrations of immunoreactive trypsin.
    Elias E; Redshaw M; Wood T
    Lancet; 1977 Jul; 2(8028):66-8. PubMed ID: 69150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A loss-of-function p.G191R variant in the anionic trypsinogen (PRSS2) gene in Japanese patients with pancreatic disorders.
    Kume K; Masamune A; Takagi Y; Kikuta K; Watanabe T; Satoh K; Satoh A; Hirota M; Hamada S; Shimosegawa T
    Gut; 2009 Jun; 58(6):820-4. PubMed ID: 19052022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive serum trypsin in diseases of the pancreas.
    Heinrich HC; Gabbe EE; Icagić F
    Klin Wochenschr; 1979 Nov; 57(22):1237-8. PubMed ID: 522426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bombesin administration on serum immunoreactive trypsin in patients with pancreatic carcinoma.
    Vezzadini P; Sternini C; Bonora G; Masserenti L; Labò G
    Panminerva Med; 1984; 26(4):279-81. PubMed ID: 6533552
    [No Abstract]   [Full Text] [Related]  

  • 14. [The significance of immunologic methods of research in several diseases of the pancreas].
    Sidorov KA; Bugrimov VG; Durov IuM
    Sov Med; 1968 Feb; 31(2):31-4. PubMed ID: 5646786
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of urine trypsinogen-2 test strip with serum lipase in the diagnosis of acute pancreatitis.
    Kylänpää-Bäck ML; Kemppainen E; Puolakkainen P; Hedström J; Haapiainen R; Korvuo A; Stenman UH
    Hepatogastroenterology; 2002; 49(46):1130-4. PubMed ID: 12143219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of serum immunoreactive trypsin concentration.
    Ruddell WS; Mitchell CJ; Hamilton I; Leek JP; Kelleher J
    Br Med J (Clin Res Ed); 1981 Nov; 283(6304):1429-32. PubMed ID: 6797570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum levels of immunoreactive anionic trypsin (but not cationic trypsin) signals pancreatic disease.
    Borgström A; Andrén-Sandberg A
    Int J Pancreatol; 1995 Dec; 18(3):221-5. PubMed ID: 8708393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arginase activity in blood serum of patients with acute and chronic pancreatitis].
    Scibior D; Ashamiss F; Wierzbicki Z; Barańczyk-Kuźma A
    Pol Merkur Lekarski; 2006 Dec; 21(126):522-4. PubMed ID: 17405289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of serum cationic trypsinogen estimation for pancreatic diseases.
    Masoero G; Andriulli A; Bianco A; Benitti V; Marchetto M; De La Pierre M
    Dig Dis Sci; 1982 Dec; 27(12):1089-94. PubMed ID: 7172958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential for differential diagnosis of autoimmune pancreatitis and pancreatic cancer using carbonic anhydrase II antibody.
    Hosoda H; Okawa-Takatsuji M; Shinmura W; Hasimoto N; Ozaki Y; Ikeda Y
    Pancreas; 2008 Jul; 37(1):e1-7. PubMed ID: 18580434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.